Internal Server Error

CellFE - About the company

CellFE is a series A company based in Berkeley (United States), founded in 2018 by Alexander Alexeev, Alla Zamarayeva, Anna Liu and Todd Sulchek. It operates as a Developer of intracellular gene delivery platform. CellFE has raised $26.8M in funding from investors like Cota Capital, M Ventures and Dynamk Capital. The company has 150 active competitors, including 42 funded and 19 that have exited. Its top competitors include companies like Genedit, Portal and Genenta Science.

Company Details

Developer of intracellular gene delivery platform. It offers a microfluidic device which delivers gene-editing molecules into the human cells. With the help of this platform, they are developing cell therapies to treat various disorders.
Key Metrics
Founded Year
2018
Location
Berkeley, United States
Stage
Series A
Total Funding
$26.8M in 5 rounds
Ranked
Employee Count
20 as on Aug 31, 2026
Similar Companies
Sign up to download CellFE's company profile

CellFE's funding and investors

CellFE has raised a total funding of $26.8M over 5 rounds. Its first funding round was on Aug 15, 2019. Its latest funding round was a Grant (prize money) round on Aug 20, 2025 for $*****. 1 investor participated in its latest round. CellFE has 14 institutional investors.

Here is the list of recent funding rounds of CellFE:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Aug 20, 2025
1695569
Grant (prize money)
8137367
9145446
4198040
1820771
Sep 27, 2023
5489214
Series A
9963923
3999690
8800009
May 01, 2020
4740639
Grant (prize money)
7409473
8427247
6324722
lockAccess funding benchmarks and valuations. Sign up today!

CellFE's founders and board of directors

Founder? Claim Profile
The founders of CellFE are Alexander Alexeev, Alla Zamarayeva, Anna Liu and Todd Sulchek.
Here are the details of CellFE's key team members:

CellFE's employee count trend

CellFE has 20 employees as of Aug 26. Here is CellFE's employee count trend over the years:
Employee count trend for CellFE
lockUncover CellFE's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

CellFE's Competitors and alternates

Top competitors of CellFE include Genedit, Portal and Genenta Science. Here is the list of Top 10 competitors of CellFE, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Genedit
Genedit
2016, Berkeley (United States), Series B
Developer of drug delivery system for genetic medicines
$93.5M
65/100
2nd
Logo for Portal
Portal
2023, Watertown (United States), Seed
Provider of cell engineering and cell analytics across research and clinical applications
$25.7M
61/100
3rd
Logo for Genenta Science
Genenta Science
2014, Milan (Italy), Public
Developer of lentivirus-based gene and cell therapies for cancer
$33.6M
59/100
4th
Logo for SonoThera
SonoThera
2022, San Francisco (United States), Series B
Developer of nonviral gene therapies for genetic diseases
$186M
58/100
5th
Developer of viral immunotherapies for the treatment of cancer
$81.6M
57/100
6th
Logo for LogicBio
LogicBio
2013, Lexington (United States), Acquired
Developer of viral vectors for the treatment of genetic and infectious diseases
$49M
57/100
7th
Logo for Recombinetics
Recombinetics
2008, New Brighton (United States), Series A
Developer of gene repair and gene-editing technology to create animal models
$66.8M
55/100
8th
Logo for ExpreS2ion Biotechnologies
ExpreS2ion Biotechnologies
2010, Copenhagen (Denmark), Public
Provider of recombinant protein production using an insect expression platform
-
52/100
9th
Logo for VIVEbiotech
VIVEbiotech
2015, San Sebastian (Spain), Seed
Developer and manufacturer of lentiviral vectors
$3.86M
51/100
10th
Logo for Andson Biotech
Andson Biotech
2021, Atlanta (United States), Series A
Provider of process analytical technologies for advanced biomanufacturing
$9.1M
51/100
13th
Logo for CellFE
CellFE
2018, Berkeley (United States), Series A
Developer of intracellular gene delivery platform
$26.8M
50/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on CellFE's competitors? Click here to see the top ones

CellFE's Investments and acquisitions

CellFE has made no investments or acquisitions yet.

Reports related to CellFE

Here is the latest report on CellFE's sector:

News related to CellFE

•
CellFE lands $4.8mVCJ•Mar 31, 2020•CellFE, Elm Street Ventures, Embark Ventures, Cota Capital and 2 others
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about CellFE

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford